Ibeoro Tablet 150 mg (Irbesartan)

Adult dose

For essential hypertension, the initial oral dose is 150 mg once daily as Irbesartan, and it may be increased to 300 mg if the effect is insufficient. In special cases, 75 mg may be considered. For kidney disease in patients with hypertension and type 2 diabetes, the recommended starting dose is 150 mg once daily, which may be increased to 300 mg for maintenance. Elderly patients (75 years and older) and patients undergoing dialysis should

This medication can cause serious harm to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients with allergic reactions to this medication, severe liver dysfunction, hereditary angioedema, women who may become pregnant, or those who are breastfeeding should not take it. Patients with impaired liver function, elderly patients, and those with hyperkalemia should use this medication with caution and be carefully monitored to avoid excessively low blood pressure. As this is a medication that lowers blood pressure, side effects such as hypotension, dizziness, and fatigue may occur, particularly during initial use of the medication. This medication may increase serum potassium levels, so caution should be taken when used in combination with potassium supplements or potassium-sparing diuretics. Patients with impaired renal function or diabetic kidney disease should have their renal function and serum potassium levels monitored regularly. During the use of this medication, serious side effects such as liver function abnormalities, angioedema, severe hypotension, renal failure, hypoglycemia, and rhabdomyolysis may occur, so any unusual symptoms should prompt immediate consultation with a physician. Interactions may occur with other antihypertensive medications, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), and lithium; therefore, it is essential to inform the healthcare provider of any co-administered medications. Caution is needed as dizziness or fatigue may occur while driving or operating machinery. Safety in pediatric patients has not been established, and elderly patients should generally start at low doses and be treated with caution. In cases of overdose, symptoms such as hypotension or tachycardia may appear, necessitating an immediate visit to a medical institution for appropriate treatment. This medication should be stored out of the reach of children and should not be transferred to other containers for safety.

Serious side effects

Urticaria, severe swelling (edema), angioedema, anaphylactic shock, anaphylactic reaction, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis,

Mild side effects

• Headache
• musculoskeletal pain
• dizziness
• fatigue
• diarrhea
• cough
• nausea/vomiting
• musculoskeletal trauma
• chest pain
• dyspepsia/heartburn

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally in a cool and dry place below 30 degrees Celsius.

Appearance

White or almost white, biconvex, oval tablets

Package unit

30 tablets/bottle, 100 tablets/bottle